Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Teclisito: Low-intensity teclistamab in the outpatient setting for Relapsed/Refractory multiple myeloma

Ana Laura Varela Constantino, Renata Quevedo-Salazar, Elias Gonzalez-Lopez, Xitlaly Gonzalez Leal, Daniela Aguilar-Perez, Jose Miguel Yañez-Reyes, Juan De Alzua-Calderon, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2025) 146 (Supplement 1): 4063.

https://doi.org/10.1182/blood-2025-4063

Published: 2025

Journal Articles

Low-dose teclistamab in newly diagnosed multiple myeloma patients

Michelle Morcos, Sofia Isabel Quezada Ramirez, Jorge Montemayor, José Emiliano Montelongo-Cepeda, Perla R. Colunga-Pedraza, Luz Tarin, Andres Gomez-De Leon, David Gomez-Almaguer

Blood (2025) 146 (Supplement 1): 4047.

https://doi.org/10.1182/blood-2025-4047

Published: 2025

Journal Articles

Revisiting accessible therapies for the management of Myelodysplastic Syndromes: A retrospective analysis of danazole, nandrolone or both.

Alejandra De Las Fuentes, Jorge Montemayor, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Yadith Karina Lopez-Garcia, Marisa Fraustro, Luis Gonzalez, Francisco Buendia-Pelaez, Andres Gomez-De Leon, Luz Tarin, César Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2025) 146 (Supplement 1): 7371.

https://doi.org/10.1182/blood-2025-7371

Published: 2025

Journal Articles

Safety and feasibility of outpatient myeloablative total marrow and lymphoid Irradiation–based allogeneic transplantation in adults with high-risk acute lymphoblastic leukemia

Alexia E. Gonzalez-Lozano, Gerardo Garcia-Salas, Miguel Campos, Michelle Morcos, Josue A. Hernandez-Benitez, César Gutierrez-Aguirre, Olga Cantu, Luz Tarin, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2025) 146 (Supplement 1): 6000.

https://doi.org/10.1182/blood-2025-6000

Published: 2025

Journal Articles

Safety of myeloablative total marrow and lymphoid irradiation versus chemotherapy-based conditioning in adults with high-risk acute lymphoblastic leukemia in a limited resources setting

Alexia E. Gonzalez-Lozano, Gerardo Garcia-Salas, Miguel Campos, Ana Laura Varela Constantino, Josue A. Hernandez-Benitez, César Gutierrez-Aguirre, Olga Cantu, Perla R. Colunga-Pedraza, Luz Tarin, Xitlaly Gonzalez Leal, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2025) 146 (Supplement 1): 5998.

https://doi.org/10.1182/blood-2025-5998

Published: 2025

Journal Articles

A multicenter real-world study on response and survival in older patients with acute myeloid leukemia treated with intensive chemotherapy versus VEN/HMA by 2022 and 2024 ELN risk stratifications: An analysis from the MARROW consortium

Blood (2025) 146 (Supplement 1): 5157.

https://doi.org/10.1182/blood-2025-5157

Published: 2025

Journal Articles

Geriatric hematologic care in Latin America: Results from a regional survey of hematology centers

Blood (2025) 146 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2025-4417

Published: 2025

Journal Articles

Aplastic anemia treatment in older adults in resource-limited settings: Can rabbit ATG bridge the gap?

Irune Marti Larrucea, Efreen Horacio Montaño Figueroa, Jose Luis Alvarez Vera, Andres Gomez-De Leon, Luis Fernando Pérez Jacobo, David Solar Cafaggi, Yadith López García, Sergio Rodríguez Rodríguez, Fernando Salazar Lagos, Leire Montoya Jimenez, Jose Antonio De La Peña, Elia Apodaca Chavez

Blood (2025) 146 (Supplement 1): 1095.

https://doi.org/10.1182/blood-2025-1095

Published: 2025

Journal Articles

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

Blood (2025) 146 (Supplement 1): 2524.

https://doi.org/10.1182/blood-2025-2524

Published: 2025

Journal Articles

The burden of hematological malignancies in Latin America and the Caribbean: A 30-year global burden of disease analysis

Héctor Alejandro Vaquera Alfaro, Alejandra De Las Fuentes, Andres Noyola-Perez, José Emiliano Montelongo-Cepeda, Sofia Isabel Quezada Ramirez, Andres Gomez-De Leon, Edward Christopher Dee, Julia Esther Colunga-Pedraza, Michelle Morcos, Alexia E. Gonzalez-Lozano, Rubi Alejandra Orta-Martinez, Olga Cantu, David Gomez-Almaguer, Luis Malpica, James Wu, Perla R. Colunga-Pedraza

Blood (2025) 146 (Supplement 1): 4615.

https://doi.org/10.1182/blood-2025-4615

Published: 2025

Journal Articles

Guaranteed care, uncertain meals: When universal coverage fails to feed

Andres Noyola-Perez, Valeria S. Narvaez-Gonzalez, Ana P. Hernandez-Lopez, Yessica M. Gonzalez-Martinez, David Gomez-Almaguer, Olga Cantu, Andres Gomez-De Leon

Blood (2025) 146 (Supplement 1): 287.

https://doi.org/10.1182/blood-2025-287

Published: 2025

Journal Articles

Expanding access in pediatrics: Outcomes of haploidentical transplantation with reduced intensity and peripheral blood stem cells

Valentine Jimenez-Antolinez, Fernando Tienda-Lopez, Paulina Garcia-Maldonado, Andres Gomez-De Leon, Julia Esther Colunga-Pedraza, Laura Villarreal-Martínez, David Gomez-Almaguer, Óscar González-Llano

Blood (2025) 146 (Supplement 1): 7714.

https://doi.org/10.1182/blood-2025-7714

Published: 2025

Journal Articles

Treatment responses and survival of newly diagnosed older or unfit patients (pts) with IDH1/2-mutated Acute Myeloid Leukemia (AML): An analysis of the MARROW consortium

Blood (2025) 146 (Supplement 1): 1626.

https://doi.org/10.1182/blood-2025-1626

Published: 2025

Journal Articles

Breaking geographic barriers in a Mexican ambulatory transplant program: Early outcomes in a diverse national and international cohort

Yadith Karina Lopez-Garcia, Alejandra De Las Fuentes, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Michelle Morcos, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Luz Tarin, Olga Cantu, César Gutierrez-Aguirre, David Gomez-Almaguer

Blood (2025) 146 (Supplement 1): 722.

https://doi.org/10.1182/blood-2025-722

Published: 2025

Journal Articles

National health systems characteristics and lymphoma outcomes: A global analysis

Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, David Gomez-Almaguer, Erin Feliciano, Edward Christopher Dee, James Wu

Blood (2025) 146 (Supplement 1): 6267.

https://doi.org/10.1182/blood-2025-6267

Published: 2025

Journal Articles

Prognostic consequences of delayed treatment in severe aplastic anemia: A challenge in resource-constrained healthcare systems

Irune Marti Larrucea, Andrea Mirelly López Flores, Efreen Horacio Montaño Figueroa, Andrés Gómez de León, Jose Alvarez, Aída Mashenka Moreno González, David Solar Cafaggi, Rodrigo Alejandro Díaz Noriega, Yadith López García, Fernando Salazar Lagos, Elia Apodaca Chavez

Blood (2025) 146 (Supplement 1): 4455.

https://doi.org/10.1182/blood-2025-4455

Published: 2025

Journal Articles

Hematopoietic cell transplantation in acute lymphoplastic leukemia: The Mexican experience

Blood (2025) 146 (Supplement 1): 4265.

https://doi.org/10.1182/blood-2025-4265

Published: 2025

Journal Articles

Topical cyclosporine vs tacrolimus for ocular GVHD prophylaxis after outpatient allogeneic hematopoietic stem cell transplantation: A Phase I–II trial

Michelle Morcos, Graciela Gonzáles-Cantú, David Gomez-Almaguer, César Gutierrez-Aguirre, Yadith Karina Lopez-Garcia, Alexia E. Gonzalez-Lozano, Perla R. Colunga-Pedraza, Luz Tarin, Andres Gomez-De Leon, Jesus Mohamed-Noriega, Karim Mohamed-Noriega, Olga Cantu

Blood (2025) 146 (Supplement 1): 2478.

https://doi.org/10.1182/blood-2025-2478

Published: 2025

Journal Articles

Enhancing graft-versus-host disease prophylaxis with modern strategies in matched-sibling or unrelated donor hematopoietic cell transplantation does not lead to higher relapse rates: A systematic review and meta-analysis of 15 randomized trials

Leonardo Arcuri, Victor Natal, Andre Americo, Mariana Kerbauy, Alberto Lima, Andrés Gómez de León, Andreza Ribeiro, Vanderson Rocha, Fabio Santos, Guilherme Perini, Nelson Hamerschlak, Carla Ribeiro

Blood (2025) 146 (Supplement 1): 2475.

https://doi.org/10.1182/blood-2025-2475

Published: 2025

Journal Articles

Short-duration blinatumomab for residual disease eradication as a bridge to transplant in B-ALL: Pediatric and adult outcomes in a resource-limited context

Paulo Ugarte-Peláez, Julia Esther Colunga-Pedraza, Francisco Rubio, Francisco Buendia-Pelaez, Luis Gonzalez, Perla R. Colunga-Pedraza, Óscar González-Llano, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2025) 146 (Supplement 1): 5135.

https://doi.org/10.1182/blood-2025-5135

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Teclisito: Low-intensity teclistamab in the outpatient setting for Relapsed/Refractory multiple myeloma

Low-dose teclistamab in newly diagnosed multiple myeloma patients

Revisiting accessible therapies for the management of Myelodysplastic Syndromes: A retrospective analysis of danazole, nandrolone or both.

Safety and feasibility of outpatient myeloablative total marrow and lymphoid Irradiation–based allogeneic transplantation in adults with high-risk acute lymphoblastic leukemia

Safety of myeloablative total marrow and lymphoid irradiation versus chemotherapy-based conditioning in adults with high-risk acute lymphoblastic leukemia in a limited resources setting

A multicenter real-world study on response and survival in older patients with acute myeloid leukemia treated with intensive chemotherapy versus VEN/HMA by 2022 and 2024 ELN risk stratifications: An analysis from the MARROW consortium

Geriatric hematologic care in Latin America: Results from a regional survey of hematology centers

Aplastic anemia treatment in older adults in resource-limited settings: Can rabbit ATG bridge the gap?

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

The burden of hematological malignancies in Latin America and the Caribbean: A 30-year global burden of disease analysis

Guaranteed care, uncertain meals: When universal coverage fails to feed

Expanding access in pediatrics: Outcomes of haploidentical transplantation with reduced intensity and peripheral blood stem cells

Treatment responses and survival of newly diagnosed older or unfit patients (pts) with IDH1/2-mutated Acute Myeloid Leukemia (AML): An analysis of the MARROW consortium

Breaking geographic barriers in a Mexican ambulatory transplant program: Early outcomes in a diverse national and international cohort

National health systems characteristics and lymphoma outcomes: A global analysis

Prognostic consequences of delayed treatment in severe aplastic anemia: A challenge in resource-constrained healthcare systems

Hematopoietic cell transplantation in acute lymphoplastic leukemia: The Mexican experience

Topical cyclosporine vs tacrolimus for ocular GVHD prophylaxis after outpatient allogeneic hematopoietic stem cell transplantation: A Phase I–II trial

Enhancing graft-versus-host disease prophylaxis with modern strategies in matched-sibling or unrelated donor hematopoietic cell transplantation does not lead to higher relapse rates: A systematic review and meta-analysis of 15 randomized trials

Short-duration blinatumomab for residual disease eradication as a bridge to transplant in B-ALL: Pediatric and adult outcomes in a resource-limited context

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only